Small Cell Lung Cancer

Filter By:
Renowned University of Pennsylvania expert Dr. Corey Langer talks about just how far we’ve come over the last three decades for a disease where the toxicities once outweighed the treatment benefits. Langer talks about progress spanning three decades, our journey towards more personalized approaches, and how many lung cancer patients today are livin...
by:patientpower | 40 views
http://cance... The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation. GRACEcast 252 Lung
by:cancergrace | 62 views
D. Ross Camidge, MD, PhD, Director, Thoracic Oncology Clinical Program, University of Colorado Cancer Center, discusses a phase I study looking at AZD9291 in patients with non-small cell lung cancer. More on lung cancer: http://www.o...
by:onclivetv | 242 views
Alex Molasiotis, RN, PhD, professor, Head of School, School of Nursing, The Hong Kong Polytechnic University, discusses the results of a pilot feasibility study looking at inspiratory muscle training for the management of breathlessness in patients with lung cancer. More from this conference: htt...
by:onclivetv | 44 views
Abraham Chachoua, MD, The Jay and Isabel Fine Associate Professor of Oncology, NYU Langone Medical Center, associate director, Cancer Services, Perlmutter Cancer Center at NYU Langone, discusses ongoing clinical trials at NYU that are evaluating immunotherapy in patients with lung cancer.
by:onclivetv | 43 views
Fadlo R. Khuri, MD, FACP, professor, chair, hematology/medi​cal oncology, Emory University School of Medicine, deputy director, Winship Cancer Institute, discusses survivorship in lung cancer.
by:onclivetv | 37 views
Scott Santarella, president, CEO, Bonnie J. Addario Lung Cancer Foundation, discusses some exciting updates in the field of lung cancer.
by:onclivetv | 56 views
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases. GRACEcast 246 Lung
by:cancergrace | 150 views
Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients. GRACEcast 242 Lung
by:cancergrace | 222 views
http://cance... Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some. GRACEcast 240 Lung
by:cancergrace | 169 views

Top Tags

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)